Eminence Capital, LP Boston Scientific Corp Transaction History

Eminence Capital, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$33.15 - $41.97 $13.4 Million - $16.9 Million	-403,812 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$34.44 - $42.23 $13.9 Million - $17.1 Million	403,812 New	403,812 $15.4 Million
Q2 2020 Aug 17, 2020	SELL	$30.19 - $39.11 $93.6 Million - $121 Million	-3,101,157 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$25.83 - $45.71 $514,972 - $911,320	19,937 Added 0.65%	3,101,157 $101 Million
Q4 2019 Feb 14, 2020	SELL	$37.87 - $45.37 $6.01 Million - $7.2 Million	-158,735 Reduced 4.9%	3,081,220 $139 Million
Q3 2019 Nov 14, 2019	SELL	$40.31 - $43.45 $2.08 Million - $2.25 Million	-51,670 Reduced 1.57%	3,239,955 $132 Million
Q2 2019 Aug 14, 2019	BUY	$34.91 - $42.98 $115 Million - $141 Million	3,291,625 New	3,291,625 $141 Million

1,607

1.19B

6.83M

10.1M

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $152B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

Get notified when there are updates to the investment portfolio of Eminence Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Eminence Capital, LP with notifications on news.